Brief: Aarti Drugs Ltd Receives 7 Inspectional Observations In Form 483 From US FDA
25/09/2024 14:40
Sept 25 (Reuters) - Aarti Drugs Ltd ADRG.NS :
* RECEIVED 7 INSPECTIONAL OBSERVATIONS IN FORM 483 FROM US
FDA
* US FDA INSPECTION WAS AT API MANUFACTURING FACILITY AT
TARAPUR
Source text for Eikon: ID:nNSEHbm5S
Further company coverage: ADRG.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees